Navigation Links
Genomic surveillance of pandemic H1N1
Date:1/21/2010

VANCOUVER, B.C. The BC Centre for Disease Control has launched an influenza genome sequencing project to better understand how the pandemic H1N1 flu virus has evolved in British Columbia, and may continue to evolve in the coming months.

This project capitalizes on BC's expertise and capacity in genome sequencing to generate hundreds of complete genomes from circulating influenza viruses collected in British Columbia during the H1N1 pandemic, as well as during and after the Olympics. By comparing the evolution of BC's influenza virus to that of viruses sequenced in other regions, researchers hope to learn how a mass gathering such as the Olympics can impact the virus' genetic sequence. The project will also allow researchers to track the geographic origins of the H1N1 virus that entered BC in 2009.

"We know from earlier studies that one of the most important drivers of an influenza virus' evolution is the mixing of different lineages of virus from around the world," explains Dr. Robert Brunham, Provincial Executive Director of the BC Centre for Disease Control. "While we are not expecting a third wave of H1N1 in BC, we will have over 250,000 visitors in Vancouver in February, which may impact influenza virus evolution."

Although researchers predict that exposure to influenza viruses from different countries will lead to changes in the H1N1 virus' genetic sequence, these changes are unlikely to change the severity of disease due to the H1N1 virus.

"The data uncovered from this project will enable BC to track how the virus moved through the population - information that can assist public health officials in understanding the virus and preparing for future outbreaks," explains Dr. Perry Kendall, British Columbia's Provincial Health Officer.

Large-scale genome projects such as this have only become common in the last five years, as sequencing technologies have improved and become faster and more cost-efficient. "This is the first time since this technology has matured that both a pandemic and an Olympics have occurred together," says Dr. Alan Winter, President and CEO of Genome BC. "The timing provides a very significant opportunity to study how a virus evolves when it is meeting and mixing with viruses from around the world."

While influenza activity has declined to baseline or below baseline levels in Canada, pandemic H1N1 activity elsewhere remains variable, with some Eastern European and Western Asian countries continuing to report above-baseline activity levels.

This project is jointly funded by the BC Centre for Disease Control, Genome British Columbia and Genome Canada. Research is being conducted at both the BCCDC Public Health Microbiology & Reference Laboratory and Canada's Michael Smith Genome Sciences Centre.


'/>"/>

Contact: Gabrielle Nye
604-790-0034
Genome BC
Source:Eurekalert

Related medicine news :

1. The Institut Curie and Ipsogen Sign a Scientific Collaboration Agreement Relating to the Genomic Grade, a Molecular Diagnostic Tool for Breast Cancer
2. NeoGenomics Announces Executive Appointments
3. Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium
4. Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress
5. Will genomics help prevent the next pandemic?
6. Genomic Health Announces Data Confirming Manual Microdissection of Biopsy Cavities Is Essential for Accurate Recurrence Risk Assessment in Early-Stage Breast Cancer Patients
7. Genomic Health to Present at the JMP Securities Healthcare Focus Conference
8. Genomic Health to Present at Two Upcoming Investor Conferences
9. Beckman Coulter Announces the Creation of Beckman Coulter Genomics
10. Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference
11. GenVaults GenSolve(TM) Reagents Enable State-of-the-Art Genomic Analysis of Dried Blood Spots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... National recruitment ... a life sciences executive with extensive sequencing and genomics experience, as Vice President of ... position, Ms. Hill will be responsible for leading the sales team in the commercialization ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... pluripotent stem (iPS) cells and other difficult to transfect cells, announces its launch ... PluriQ™ G9™ Gene Editing System is a complete system for culturing ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: